. 2019 Aug 5;8(15):e012482. doi: 10.1161/JAHA.119.012482

Table 4.

Variables With Significant Correlation to Worse Outcome Included in Univariate and Multivariate Analysis

	Univariate Analysis		Multivariate Analysis
	HR (95% CI)	P Value	HR (95% CI)	P Value
Combined events=all‐cause mortality and VT recurrence
Fat deposition	2.85 (1.25–6.5)	0.013^a	2.69 (1.12–6.46)	0.027^a
3‐vessel disease	2.02 (1.02–4.01)	0.044^a	2.03 (0.98–4.18)	0.056
LVEF <35%	2.23 (1.10–4.53)	0.026^a	2.57 (1.13–5.86)	0.024^a
Scar extent	1.04 (0.94–1.15)	0.45	0.59 (0.32–1.11)	0.10
Smoking	1.05 (0.76–1.45)	0.78	1.13 (0.79–1.16)	0.50
Diabetes mellitus	1.03 (0.62–1.38)	0.90	1.00 (0.57–1.78)	0.99
Redo procedure	1.43 (0.83–2.84)	0.20	1.45 (0.8–2.63)	0.22
Age	0.99 (0.96–1.02)	0.48
Scar age	1.25 (0.70–2.22)	0.45
VT recurrence
Fat deposition	2.64 (1.06–6.6)	0.037	2.91 (1.10–7.75)	0.033^a
LVEF <35%	2.38 (1.03–5.50)	0.042	2.05 (0.82–5.13)	0.12
Inducible after ablation	1.65 (1.03–2.66)	0.038	1.49 (0.89–2.50)	0.13
Scar extent	1.12 (0.63–1.99)	0.70	1.00 (0.86–1.16)	0.97
Scar age	1.34 (0.90–2.00)	0.15	1.02 (0.63–1.64)	0.94
Diabetes mellitus	1.05 (0.58–1.90)	0.87
3‐vessel disease	1.36 (0.52–3.60)	0.53
Age	0.98 (0.96–1.01)	0.31
Acute procedural complication	0.97 (0.28–3.34)	0.96

HR indicates hazard ratio; LVEF, left ventricular ejection fraction; VT, ventricular tachycardia.

P≤0.05.